Skip to main content

Davis Andrew S.'s Form 4 filing

Silk Road Medical Inc (SILK) · filed May 3, 2023

Accession no.
0001593968-23-000739
Filed
May 3, 2023
Trade date
May 1, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 8 non-derivative transactions and 4 derivative transactions. Open-market sales total $300.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Davis Andrew S.CIK 0001770191Officer (Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 1, 2023Common StockMOption exerciseAcquired+482$6.11+$2,945.02116,165Direct
May 1, 2023Common StockMOption exerciseAcquired+474$20.00+$9,480116,639Direct
May 1, 2023Common StockMOption exerciseAcquired+2,584$4.73+$12,222.32119,223Direct
May 1, 2023Common StockMOption exerciseAcquired+3,213$4.73+$15,197.49122,436Direct
May 1, 2023Common StockSSaleDisposed−482$44.51F2−$21,453.82121,954Direct
May 1, 2023Common StockSSaleDisposed−474$44.51F2−$21,097.74121,480Direct
May 1, 2023Common StockSSaleDisposed−2,584$44.51F2−$115,013.84118,896Direct
May 1, 2023Common StockSSaleDisposed−3,213$44.51F2−$143,010.63115,683Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 1, 2023Common StockMOption exerciseDisposed−3,213$0.00$044,238Direct
May 1, 2023Common StockMOption exerciseDisposed−482$0.00$01,853Direct
May 1, 2023Common StockMOption exerciseDisposed−474$0.00$033,220Direct
May 1, 2023Common StockMOption exerciseDisposed−2,584$0.00$018,720Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at price ranging from $43.99 to $45.02. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 4 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)